Vanda Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Vanda Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $14.13. The average 1-year stock price forecast is 137.48% higher than the current stock price, while the lowest is $7.50 (+26.05%) and the highest is $21 (+252.94%).

Price Target: $14.13 (+137.48%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.50	$14.13	$14	$21
Change	+26.05%	+137.48%	+135.29%	+252.94%

Analyst Ratings

The average analyst rating for Vanda Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	4	4	4	3
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	5	5	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $21	Buy	Reiterates	$21	+252.94%	Jun 4, 2026
Les Sulewski Truist Financial	Truist Financial	Buy Maintains $18	Buy	Maintains	$18	+202.52%	May 7, 2026
Madison Elsaadi B. Riley Securities	B. Riley Securities	Buy Maintains $14 → $17	Buy	Maintains	$14 → $17	+185.71%	Feb 25, 2026
Olivia Brayer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $11	Buy	Maintains	$11	+84.87%	Feb 23, 2026
Andrew Tsai Jefferies	Jefferies	Hold Maintains $5 → $7.5	Hold	Maintains	$5 → $7.5	+26.05%	Dec 31, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

262.00M

from 216.11M

21.24%

from 216.11M

Revenue Next Year

356.60M

from 262.00M

36.10%

from 262.00M

EPS This Year

0.96

from -

EPS Next Year

1.04

from 0.96

8.33%

from 0.96

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	268.68M	254.38M	192.64M	198.77M	216.11M	262.00M
Revenue Growth	8.27%	-5.32%	-24.27%	3.18%	8.72%	21.24%
Gross Profit	243.05M	230.10M	177.84M	187.46M	203.06M	246.28M
Gross Margin	90.46%	90.45%	92.32%	94.31%	93.96%	94.00%
Operating Income	42.17M	6.33M	-13.95M	-40.66M	-151.17M	-147.80M
Net Income	33.15M	6.28M	2.51M	-18.90M	-220.47M	-135.48M
EPS	-	-	-	-	-	0.96
Forward PE	21.94	21.74	-	-	-	6.20
Free Cash Flow	48.22M	32.34M	-87.45M	-17.05M	-49.36M	-140.00M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	266.8M
Avg	262.0M
Low	259.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	23.5%
Avg	21.2%
Low	20.1%

EPS Forecast

EPS	2026	2027	2028
High	0.96
Avg	0.96
Low	0.96

EPS Growth

EPS Growth	2027	2028
High	8.3%
Avg	8.3%
Low	8.3%